Finoriq

Finoriq research workspace

STRYKER CORP (SYK) Company Overview

Stryker Corporation operates as a medical technology company in the United States and internationally. Review SYK filings, fundamentals, valuation, and ownership on Finoriq.

Company Snapshot

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Company
STRYKER CORP (SYK)
Ticker
SYK
Market Cap
$122.5B
Latest Price
$319.55
Industry
Medical Devices

Open insider transactions

STRYKER CORP (SYK) Current Valuation Metrics

Static valuation preview for STRYKER CORP (SYK). Market data retrieved 2026-06-19. Filing currency USD.

MetricValueSource
P/EMarket cap divided by latest TTM net income.35.4xNet Income | TTM Q1 2026
P/SMarket cap divided by latest TTM revenue.4.67xRevenue | TTM Q1 2026
P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow.22.0xOperating Cash Flow | TTM Q1 2026
Earnings YieldLatest TTM net income divided by market cap.2.8%Net Income | TTM Q1 2026
Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap.4.6%Operating Cash Flow | TTM Q1 2026

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.